Swisscom participated in a series B round where Sophia Genetics raised $13.8m, taking its overall funding to more than $16.5m.
Sophia Genetics, a Switzerland-based specialist in data-driven medicine, has raised $13.75m in a series B round led by Invoke Capital that also included telecommunications company Swisscom and Endeavour Vision.
Apart from the cash injection, Sophia gains access to Invoke’s portfolio company Genalys, which uses big data mathematics to analyse genomic information.
Spun out of the Federal Institute of Technology Lausanne in 2011, Sophia’s technology makes it possible to diagnose genetic diseases and the DNA of cancer tumours through a combination…
